Literature DB >> 19249942

Fibrin as a delivery system for therapeutic drugs and biomolecules.

Ailish Breen1, Timothy O'Brien, Abhay Pandit.   

Abstract

Fibrin is a natural biopolymer involved in the coagulation cascade. It acts as a reservoir for growth factors, cells, and enzymes during wound healing and provides a scaffold for the synthesis of extracellular matrix. Thus, the use of fibrin has expanded in recent years from traditional use as a sealant for surgical applications, to a tissue engineering scaffold capable of providing nature's cues for tissue regeneration. This paper reviews the advantageous biological aspects of fibrin, the history of the scaffold material, and its present role in the delivery of drugs, growth factors, cells, and gene vectors. Examples are given of studies where the structure and form of the scaffold have been manipulated for optimal release of the therapeutic agent, optimal cellular activity, and investigation into stem cell differentiation. It is evident from the body of literature presented that the benefits of fibrin are being exploited for a vast range of tissue engineering applications and that fibrin remains a key scaffold material for the delivery of drugs and biomolecules.

Mesh:

Substances:

Year:  2009        PMID: 19249942     DOI: 10.1089/ten.TEB.2008.0527

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  44 in total

1.  Preparation of 3D fibrin scaffolds for stem cell culture applications.

Authors:  Kathleen Kolehmainen; Stephanie M Willerth
Journal:  J Vis Exp       Date:  2012-03-02       Impact factor: 1.355

2.  Effect of Fibrin Formulation on Initial Strength of Tendon Repair and Migration of Bone Marrow Stromal Cells in Vitro.

Authors:  Kosuke Uehara; Chunfeng Zhao; Anne Gingery; Andrew R Thoreson; Kai-Nan An; Peter C Amadio
Journal:  J Bone Joint Surg Am       Date:  2015-11-04       Impact factor: 5.284

3.  Effect of Bone Powder/Mesenchymal Stem Cell/BMP2/Fibrin Glue on Osteogenesis in a Mastoid Obliteration Model.

Authors:  Chul Ho Jang; Gwang Won Cho; An-Ji Song
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

4.  A safe and efficient method to retrieve mesenchymal stem cells from three-dimensional fibrin gels.

Authors:  Bita Carrion; Isaac A Janson; Yen P Kong; Andrew J Putnam
Journal:  Tissue Eng Part C Methods       Date:  2013-08-14       Impact factor: 3.056

5.  Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations.

Authors:  Hannah H Lee; Amgad M Haleem; Veronica Yao; Juan Li; Xiao Xiao; Constance R Chu
Journal:  Tissue Eng Part A       Date:  2011-05-11       Impact factor: 3.845

Review 6.  Biomaterials to prevascularize engineered tissues.

Authors:  Lei Tian; Steven C George
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

7.  Phase-separated chitosan-fibrin microbeads for cell delivery.

Authors:  Zhewei Chen; Limin Wang; Jan P Stegemann
Journal:  J Microencapsul       Date:  2011       Impact factor: 3.142

8.  Antimicrobial drugs encapsulated in fibrin nanoparticles for treating microbial infested wounds.

Authors:  B Maria Alphonsa; P T Sudheesh Kumar; G Praveen; Raja Biswas; K P Chennazhi; R Jayakumar
Journal:  Pharm Res       Date:  2013-11-28       Impact factor: 4.200

9.  Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF164.

Authors:  Veronica Sacchi; Rainer Mittermayr; Joachim Hartinger; Mikaël M Martino; Kristen M Lorentz; Susanne Wolbank; Anna Hofmann; Remo A Largo; Jeffrey S Marschall; Elena Groppa; Roberto Gianni-Barrera; Martin Ehrbar; Jeffrey A Hubbell; Heinz Redl; Andrea Banfi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

10.  Fibrin-mediated delivery of an ovarian follicle pool in a mouse model of infertility.

Authors:  Rachel M Smith; Ariella Shikanov; Ekaterina Kniazeva; Deepa Ramadurai; Teresa K Woodruff; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2014-06-12       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.